Intracytoplasmic sperm injection after follicle stimulation with highly purified human follicle-stimulating hormone compared with human menopausal gonadotropin

Journal of Assisted Reproduction and Genetics

Volumn 16, Issue 2, 1999, Pages 63-68

  Weissman, Ariel ^a   Meriano, James ^b   Ward, Susan ^b   Gotlieb, Lynda ^a   Casper, Robert F ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

GnRH a; hMG; ICSI; Oocyte maturity; Pure FSH

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; CELL AGING; CYTOPLASM; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; MENOTROPINS; MICROINJECTIONS; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032976043     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022560621444     Document Type: Article

References (21)

1. Tan SL: Simplifying in-vitro fertilization therapy. Curr Opin Obstet Gynecol 1994;6:111-114
2. Wikland M, Borg J, Hamberger L, Svalander P: Simplification of IVF: Minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum Reprod 1994;9:1430-1436
3. Howles CM, Loumaye E, Giroud D, Luyet G: Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: A multicentre European phase III study. Hum Reprod 1994;9:424-430
4. Out HJ, Mannaerts BM, Driessen SG, Coelingh-Bennink HJ: A prospective, randomized, assessor-blind, muticentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon vs Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-2540
5. Recombinant FSH Study Group: Clinical assessment of recombinant follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil Steril 1995;63:77-86
6. Greenblatt E, Meriano JS Casper RF: Type of stimulation protocol affects oocyte maturity, fertilization rate, and cleavage rate after intracytoplasmic sperm injection. Fertil Steril 1995;64:557-563
7. Veeck LL: Oocyte assessment and biological performance. Ann NY Acad Sci 1988;541:259-274
8. Veeck LL: Atlas of the Human Oocyte and Early Conceptus. Baltimore, Williams & Wilkins, 1991, Vol 2, pp 121-149
9. Imthurn B, Macas E, Rosseli M, Keller PJ: Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotropin. Hum Reprod 1996;11:1387-1391
10. Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810-814
11. Mercan R, Mayer JF, Walker D, Jones S, Oehninger S, Toner JP, Muasher SJ: Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. Hum Reprod 1997;12:1886-1889
12. Fried G, Harlin J, Csemiczky, Wramsby H: Controlled ovarian stimulation using highly purified FSH results in a lower serum ooestradiol profile in the follicular phase as compared with HMG. Hum Reprod 1996;11:474-477
13. Westergaard LG, Erb K, Laursen S, Rasmussen PE, Rex S: The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod 1996;11:1209-1213
14. Fleming R, Chung CC, Yates RWS, Coutts JRT: Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod 1996;11:1854-1858
15. Soderstrom-Anttila V, Foudila T, Hovatta O: A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotropin for ovarian hyper-stimulation in an oocyte donation program. Hum Reprod 1996;11:1864-1870
16. Hillier SG, Smyth CD, Whitelaw PF, Miro F, Howles CM: Gonadotrophin control of follicular function. Horm Res 1995;43:216-223
17. Catt KS, Dufau ML: Spare gonadotropin receptors in rat testes. Nature 1977;244NB:219-221
18. Doerr P: Relationship between saturation of LH receptors and steroidogenic response in isolated rat granulosa cells. Horm Metab Res 1979;11:181-182
19. Miron P, Casper RF, Raymond L: Comparison between highly purified FSH and hMG for superovulation in women undergoing in vitro fertilization. J Soc Obstet Gynecol Can (in press)
20. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M: Recombinant human stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-2139
21. Loumaye E, Engrand P, Howles C, O'Dea L: Assessment of the role of serum luteinizing hormone and estradiol response to follicle stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 1997;67:889-899